首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到19条相似文献,搜索用时 493 毫秒
1.
聚合物对泌尿系结石的形成具有抑制和促进双重作用。本文综述了聚合物对尿石矿物草酸钙成核、生长、聚集及其与尿路细胞膜黏附影响的研究进展,讨论了聚合物影响草酸钙晶面和形貌的机理,指出了该领域所面临的问题和将来的发展方向。  相似文献   

2.
不同介质凝胶体系中草酸钙结晶的研究   总被引:2,自引:0,他引:2  
研究了五种不同介质(水、氯化钠、合成尿、正常人尿液和尿石患者尿液)的凝胶体系中草酸钙(CaC2O4)晶体的生长,及各种体系中防石药物柠檬酸钾(K3cit)对CaC2O4生长的影响.没有加K3cit时,CaC2O4晶体以一水草酸钙(calcium oxalate monohydrate, COM)为主要物相,但在氯化钠和合成尿的凝胶体系中同时出现了二水草酸钙(calcium oxalate dihydrate, COD)和三水草酸钙(calcium oxalate trihydrate, COT),肾结石患者尿液中出现COD,而正常人尿液中没有COD和COT生成.加入K3cit后,水、氯化钠和合成尿介质的凝胶体系中,COT的含量显著增加,患者尿液中产生大量COD,而正常人尿液中出现了少量的COD和极个别的COT.COT的增加与低温、体系中高的离子强度及金属离子等因素有关.K3cit具有诱导COD和COT的生成、减小COM晶体比表面积的作用,从而有利于防治草酸钙结石的形成.  相似文献   

3.
枸橼酸盐抑制泌尿系结石形成的化学基础   总被引:7,自引:0,他引:7  
欧阳健明 《无机化学学报》2004,20(12):1377-1382
本文综述了防石药物枸橼酸及其盐对泌尿系结石形成、抑制和治疗的化学基础,重点讨论了其与钙离子的配位、封闭尿石矿物生长活性位点、抑制草酸钙的成核和生长、增加尿液中尿大分子和枸橼酸浓度、改变尿液pH以及诱导二水草酸钙和三水草酸钙形成,并讨论了抗衡阳离子对枸橼酸盐抑制能力的影响。  相似文献   

4.
对近5年来水中化学需氧量(COD)检测方法特点及其研究进展进行回顾和总结,概述了COD检测现有标准方法的优缺点及其改进方面的研究状况,并对分光光度法、吸收光谱法、电化学分析法、流动注射法以及在线检测技术等文献报道方法进行综述,分析了各检测方法的特点,展望了COD检测方法未来的发展趋势。  相似文献   

5.
硅凝胶体系中不同结构羧酸钾对草酸钙结晶的影响   总被引:1,自引:0,他引:1  
采用扫描电子显微镜(SEM)和X射线衍射(XRD)方法研究了硅凝胶体系中不同种类羧酸钾对草酸钙(CaC2O4)晶体生长的调控作用. 加入一元醋酸钾(KOAc)只生成一水草酸钙(COM)晶体; 三元柠檬酸钾(K3Cit)和四元乙二胺四乙酸二钾(K2EDTA)可诱导二水草酸钙(COD)形成, 且随着其浓度增加, 对COD的诱导能力增加, 而二元酒石酸钾(K2Tart)同时诱导了COM, COD和三水草酸钙(COT)生成. 随着结晶温度降低, 多元酸钾可以进一步减小COM晶体的比表面积, 增加COD的百分含量, 但K2Tart诱导COT的能力减弱. 由于诱导COD和COT晶体形成、减小COM的比表面积均有利于防止草酸钙尿石的形成, 因此, 多元羧酸钾可用于草酸钙结石的预防和治疗.  相似文献   

6.
柳一鸣  欧阳健明  邓芳  郑辉 《化学学报》2006,64(14):1446-1450
采用扫描电子显微镜(SEM)和X射线衍射法(XRD)研究了土家族药物天葵化石汤(Tiankui)的提取液对尿石晶体草酸钙(CaOxa)成核、生长的抑制作用及其对二水草酸钙(COD)的稳定作用. 当Tiankui浓度小于30 mg/mL时, 主要生成一水草酸钙(COM), 但可使COM晶体棱角圆钝. 随着Tiankui浓度增加至45和75 mg/mL, 可分别诱导95%和100%的COD晶体生成. Tiankui还可以稳定COD在水溶液中的存在, 没有Tiankui存在时, COD在48 h内全部转化为COM晶体, 而在12 mg/mL Tiankui存在下, COD仅有20%转化. 从Tiankui提取液的活性组分、与草酸钙不同晶相间的吸附差异、化学配位等角度讨论了其抑制CaOxa生长和诱导稳定COD的化学基础.  相似文献   

7.
本文探讨了酒石酸及其盐对泌尿系结石形成、抑制和治疗的化学基础,重点讨论了其与钙离子的螯合,诱导二水草酸钙和三水草酸钙形成、减少晶体滞留,影响CaOxa晶体的晶面与形貌,抑制尿石矿物的成核、生长和聚集,调节新陈代谢、减小尿石形成的几率,并讨论了抗衡阳离子对其抑制能力的影响。  相似文献   

8.
植物药抑制泌尿系结石形成的化学基础   总被引:1,自引:0,他引:1  
植物药治疗泌尿系结石具有独特的疗效.本文综述了国内外植物药(泽泻,Phyllanthus niruri,Zeamays,Agropyron repens和Herniaria hirsute等)在体外模拟实验和动物实验中对泌尿系结石形成的影响,植物药抑制泌尿系结石形成的机制和化学基础是:植物药与钙离子发生配位,降低尿石盐的过饱和度;抑制一水草酸钙生长,诱导二水草酸钙形成;抑制晶体生长和聚集;可以保护尿路粘膜,防止晶体在肾上皮细胞上发生粘附;改变尿石形成促进剂和抑制剂的排泄量.  相似文献   

9.
肾结石的主要组分是草酸钙(CaOxa)等晶体。目前肾结石只能在形成以后才能被诊断,这给患者带来了极大的痛苦。肾结石的形成与尿液中的纳米微晶性质密切相关,如果能在结石形成之前或形成初期早期检测,则可以有效地预防肾结石发生发展。本文结合本课题组的工作,从微晶尺寸、微晶的聚集程度、形貌、化学组分、Zeta电位和稳定性等方面综述了肾结石患者尿液中纳米微晶的性质差异及其与肾结石形成的关系,并与健康对照者进行了比较;讨论了CaOxa结石患者在服用防石药物柠檬酸钾后尿微晶的性质变化。研究结果表明尿液中的纳米微晶的聚集是导致微晶快速增大和结石形成的关键因素,说明通过调控纳米微晶的物理、化学性质,有可能抑制肾结石的形成和复发。  相似文献   

10.
草酸钙结石的形成与尿液中草酸钙的存在形式密切相关,一水草酸钙(COM)促进尿石症形成,而二水草酸钙(COD)易随尿液排出体外。本文采用体外模拟方法,比较研究了COD晶体在水溶液、正常人尿液和结石患者尿液3个不同体系中的稳定性及海藻龙须菜多糖(SPS)对COD的稳定作用。在水溶液和患者尿液中,不但COD转化率高,而且得到的转化产物COM晶体聚集程度大;而在正常人尿液中,COD转化率低,转化产物聚集程度较小。COD在不同体系中转化的速度依次为:水溶液>患者尿液>正常人尿液。从海藻龙须菜中提取的硫酸多糖可以稳定COD的存在并减小COM的聚集,这有利于阻止草酸钙结石的形成,因此,海藻龙须菜多糖有可能用于防止草酸钙结石形成。  相似文献   

11.
Kidney stone disease causes substantial suffering and occasional renal failure. The content of calcium oxalate (CaOxa) is up to 70-80% in the stones1,2. However, the mechanism of the formation of urinary stones is not yet clearly understood and the questi…  相似文献   

12.
凝胶体系中不同结构羧酸盐对草酸钙生物矿化的影响   总被引:4,自引:0,他引:4  
采用双扩散法研究了凝胶体系中四元羧酸盐(Na2EDTA)、三元羧酸盐柠檬酸钠(Na3cit)、二元羧酸盐酒石酸钠(Na2tart)和一元羧酸盐醋酸钠(NaAc)对草酸钙(CaOx)结晶的影响.抑制一水草酸钙(COM)聚集的能力为:Na2EDTA >Na3cit >Na2tart >NaAc;诱导二水草酸钙(COD)的能力为:Na3cit >Na2tart >Na2EDTA >NaAc.羧酸的抗衡阳离子影响CaOx的结晶. H3cit、Na3cit和K3cit抑制COM聚集和诱导COD形成的能力均为:K3cit-Na3cit >H3cit.无论是诱导COD生成,还是抑制COM聚集,均可以减小结石形成的几率,对临床上防治结石具有积极的意义.  相似文献   

13.
采用扫描电子显微镜(SEM)、 红外光谱(FTIR)和X射线衍射(XRD)方法研究了从海藻异枝麒麟菜中提取的硫酸多糖(ESPS)对草酸钙(CaOxa)晶体生长的影响. 结果表明, 添加ESPS能抑制一水草酸钙(COM)的生长, 同时诱导二水草酸钙(COD)晶体的形成. 随着ESPS的质量浓度从0增加到0.03和0.50 mg/mL, COD的质量分数从0分别增加到10%和55%; COM的(1 01)晶面加强, (020)晶面减弱直至消失, 并从三维晶体转变为棱角圆顿的四角形片状晶体; COM和COD的尺寸均明显变小. 这些结果表明, ESPS是抑制CaOxa结石形成的一种潜在药物.  相似文献   

14.
The human urinary calculi are mainly constituted by calcium oxalate, magnesium ammonium phosphate hexahydrate, and uric acid. The ions or molecules are easily characterized by wet chemical methods. The difficulties appear in the differentiation of the hydrates of calcium oxalate (monohydrate COM or Whewellite, and dihydrate COD or Weddelite). A high level of COD in the urinary stones leads, often, inflammation, sharp pain and blood in urine. In the worse cases, they must be extracted by surgical way. The identification of the main components of urinary calculi, the knowledge of the true number of water molecules bounded to the calcium oxalate, and the determination of each hydrate in the mixture, are the interests of this memory. The thermal analysis (simultaneous DTA-TG) was applied on thirty-three urinary calculi. The determination of the calcium oxalate hydrates was confirmed by calorimetry (DSC). This revised version was published online in July 2006 with corrections to the Cover Date.  相似文献   

15.
Various crystals are seen in human urine. Oxalate, Phosphate, Uric acid, and Urate crystals are generally seen in urinary calculi. Calcium stones are most common, comprising 75 % of all urinary calculi. They may be pure calcium oxalate or calcium phosphate or a mixture of both. Many stones are not homogeneous. Low calcium intake increases the intestinal absorption of calcium, thus decreasing the amount of calcium available in the intestinal tract to form insoluble complexes with Oxalate. Consequently, a higher amount of oxalate is available for intestinal absorption and as a result, urinary oxalate excretion increases. Mineral water consumption did not reduce urinary oxalate excretion. High urinary excretion and concentration of magnesium decrease both the nucleation and growth rates of calcium oxalate crystals in urine, because of the higher solubility of magnesium oxalate compared with calcium oxalate. Analytical results show calcium oxalate to be one of the major inorganic components of renal stones and found to be present in almost all kidney and bladder stones. About 39.5 % of the total composition of the calculi is found to contain purely calcium oxalate and also hydroxyl apatite. The ten samples are a mixture of calcium oxalate and phosphate stones. Four samples are calcium oxalate as major composition and the remaining are calcium phosphate as major composition. These kidney stones are taken photographically and size of the stone are measured using optical microscopy. These qualitative analyses are also confirmed by UV, FTIR, DSC, and XRD analysis.  相似文献   

16.
大豆多糖对尿石矿物草酸钙形成的调控作用   总被引:1,自引:0,他引:1  
采用水提法从大豆中提取了大豆多糖(SPS),其多糖百分含量为97.38%;平均相对分子质量为115,200,羧基百分含量为13.8%。采用X射线衍射法(XRD)、红外光谱(FTIR)、扫描电子显微镜(SEM)和电感耦合等离子体发射光谱仪(ICP)研究了水溶性大豆多糖(SPS)对草酸钙晶体生长的调控作用。SPS大豆多糖不但可以抑制一水草酸钙(COM)晶体的聚集,而且可以诱导二水草酸钙(COD)晶体形成。当SPS浓度由0增大到0.50g·L-1时,草酸钙晶体由COM完全转变为COD晶体;并且随着多糖浓度的增大,溶解在溶液中的钙离子(可溶性钙)浓度显著增加,草酸钙沉淀的物质的量逐渐减少。这些结果表明,SPS有望成为预防草酸钙结石的一种绿色药物。  相似文献   

17.
The formation of calcium oxalate kidney stones was related to injuries of renal epithelial membranes. The liquid condensed (LC) domains in Langmuir‐Blodgett (LB) film of dipalmitoylphosphatidylcholine (DPPC) were used as a model system to induce crystal growth of urinary mineral calcium oxalate monohydrate (COM). The circular defective boundaries between the LC and liquid expanded (LE) phases of the DPPC monolayer could provide much more nucleating sites for crystallization of COM crystals. It induced ring‐shaped or solid circular patterns of COM crystals on hydrophobic quartz substrates depending on the crystallization time.  相似文献   

18.
玉米须提取液对尿液中草酸钙晶体形成的影响   总被引:3,自引:0,他引:3  
本文采用X射线衍射(XRD)、红外光谱(FTIR)、扫描电子显微镜(SEM)等方法分析了玉米须提取液对正常人尿液中草酸钙晶体形成的影响,通过电导率法研究了草酸钙晶体生长的动力学过程,以及从生物矿化的角度对玉米须提取液影响尿液中草酸钙晶体的可能机理进行了探讨。由于玉米须提取液中有机酸或多糖的羟基、羰基等通过配位作用与Ca2+结合形成可溶性配位化合物,减少了Ca2+与Oxa2-的结合能力,从而抑制了CaOxa的成核和生长。同时,可能由于玉米须提取液中有效成分与二水草酸钙(COD)的吸附点键合,增强了COD晶体在溶液中的热力学稳定性,进而抑制了COD晶体向热力学更稳定态的一水草酸钙(COM)晶体转变。结果显示,这种抑制作用随玉米须浓度增大而增大,且COD晶体尺寸随着玉米须浓度的增大而减小。玉米须抑制COD晶体向COM晶体转变的作用为开发预防和治疗尿结石的药物提供了启示。  相似文献   

19.
Calcium oxalate (CaOx) particles with different morphologies and phase structures were prepared by a facile precipitation reaction of sodium oxalate with calcium chloride in the absence and presence of poly(sodium 4-styrene-sulfonate) (PSSS) at different temperatures. The as-prepared products were characterized with scanning electron microscopy and X-ray diffraction. The influence of experimental conditions including pH, temperature, and concentration of PSSS and CaC2O4 on the morphologies and phase structures of the prepared calcium oxalate particles were investigated. It was found that variations in the concentration of PSSS and CaC2O4, temperature, and pH significantly influenced the crystal structure, morphology, and particle size of the samples. Various crystal morphologies of calcium oxalate, such as plate, leaf-shaped, bipyramid, and cylinder could be fabricated, depending on the experimental conditions. Higher PSSS concentration and reaction temperature favored the formation of metastable calcium oxalate dihydrate (COD) crystals and stable calcium oxalate monohydrate (COM), respectively. Especially, cylinder-shaped CaC2O4 particles were obtained at 80 degrees C in the presence of PSSS for the first time. This research may provide new insight into understanding and potentially regulating the formation of kidney stones and the control of morphology and phase structures of calcium oxalate particles.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号